Differential expression of LOXL4 in normal and tumour tissue samples of laryngeal squamous cell carcinoma.

about

Lysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and Cancer.

P2860

Q38723997-57E2959E-E77D-4444-8C38-0E14FD4D023B

P2860

Differential expression of LOXL4 in normal and tumour tissue samples of laryngeal squamous cell carcinoma.

Item

http://www.wikidata.org/entity/Q50540766

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Differential expression of LOX ...... ngeal squamous cell carcinoma.

@en

Differential expression of LOX ...... ngeal squamous cell carcinoma.

@nl

type

Item

label

Differential expression of LOX ...... ngeal squamous cell carcinoma.

@en

Differential expression of LOX ...... ngeal squamous cell carcinoma.

@nl

prefLabel

Differential expression of LOX ...... ngeal squamous cell carcinoma.

@en

Differential expression of LOX ...... ngeal squamous cell carcinoma.

@nl

P1476

Differential expression of LOX ...... ngeal squamous cell carcinoma.

@en

P2093

H Cansiz

http://www.w3.org/2001/XMLSchema#string

I Suer

http://www.w3.org/2001/XMLSchema#string

M Yilmaz

http://www.w3.org/2001/XMLSchema#string

O F Karatas

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Cancer statistics, 2014

Radiotherapy or CO(2) laser surgery as treatment of T(1a) glottic carcinoma?

Cloning and characterization of a fifth human lysyl oxidase isoenzyme: the third member of the lysyl oxidase-related subfamily with four scavenger receptor cysteine-rich domains.

Molecular markers in laryngeal squamous cell carcinoma: towards an integrated clinicobiological approach.

Alpha B-crystallin is a new prognostic marker for laryngeal squamous cell carcinoma

The molecular biology of head and neck cancer.

LOXL4 is a selectively expressed candidate diagnostic antigen in head and neck cancer.

LOXL1 and LOXL4 are epigenetically silenced and can inhibit ras/extracellular signal-regulated kinase signaling pathway in human bladder cancer.

Selective upregulation and amplification of the lysyl oxidase like-4 (LOXL4) gene in head and neck squamous cell carcinoma.

P304

206-210

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/COA.12498

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mustafa Ozen

P577

2015-07-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26138381

http://www.w3.org/2001/XMLSchema#string

P921

Bagtingan

Differential expression of LOXL4 in normal and tumour tissue samples of laryngeal squamous cell carcinoma.

about

P2860

P2860

Differential expression of LOXL4 in normal and tumour tissue samples of laryngeal squamous cell carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921